Miist Therapeutics

Miist Therapeutics

Private
Alameda, CaliforniaHealthcare & Life Scienceshttps://www.miisttherapeutics.com

Last Round

Seed

Feb 5, 2025

Total Funding Raised

$7M

Company Overview

Miist Therapeutics is a biotechnology company that develops inhaled therapies designed for rapid symptom relief.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials

Business Model

B2B2C

Customer Profile

Hardware + Subscription

AI Layer

Non-AI

Keywords

drug delivery platforminhaled therapiessmart inhalerdrug-device combinationpulmonary drug deliverysmoking cessationmigraine therapycombo productrapid symptom relieffast-acting medicationultrasonic nebulizervibrating mesh nebulizeraerosol drug deliveryclinical-stage biopharmaplatform licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Miist Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Miist Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 5, 2025

Key People

Founding team and executive leadership

Dalton Signor

Founder And CEO

Founding Team

Miist Therapeutics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 5, 2025

    $7M round completed.

Miist Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Miist Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Miist Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersAlameda, California
Employee Range7
Year FoundedN/A
Last FundingFeb 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.